Noncombustible Nicotine Delivery Systems as Potential Harm Reduction Tools for Persistent Cigarette Smokers
Alternative Nicotine Delivery Systems as Potential Harm Reduction Tools for Persistent Cigarette Smokers
Sponsor: Abramson Cancer Center at Penn Medicine
Listed as NCT06372899, this NA trial focuses on Cigarette Smoking and E-cigarette Use and remains actively recruiting participants. Sponsored by Abramson Cancer Center at Penn Medicine, it has been updated 9 times since 2024, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
9 versions recorded-
Mar 2026 — Present [monthly]
Recruiting NA
-
Feb 2026 — Mar 2026 [monthly]
Recruiting NA
-
May 2025 — Feb 2026 [monthly]
Recruiting NA
-
Nov 2024 — May 2025 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Oct 2024 — Nov 2024 [monthly]
Not Yet Recruiting NA
▶ Show 4 earlier versions
-
Sep 2024 — Oct 2024 [monthly]
Not Yet Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Not Yet Recruiting NA
-
Jun 2024 — Jul 2024 [monthly]
Not Yet Recruiting NA
-
May 2024 — Jun 2024 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Abramson Cancer Center at Penn Medicine
- National Cancer Institute (NCI)
- University of Pennsylvania
For direct contact, visit the study record on ClinicalTrials.gov .